Thomas W Martens, MD

CGM is now standard of care in T1D and evidence is solid for a role in insulin-treated T2D; Thomas Martens, MD, shares thoughts on CGM growth in the next 3-5 years.

Martens, medical director of the International Diabetes Center (IDC) in Minneapolis, highlights an IDC resource that helps target problem areas in management of hyperglycemia.

Martens, Director of the International Diabetes Center, in Minneapolis, highlights the differences between the 2 methods and what the research has found on each.

ACP 2025. The timely glucose data available with continuous glucose monitoring is what's needed for optimal daily diabetes control, says Tom Martens, MD.